Quantcast
Home / Opinion Digests / Administrative – FDA Drug Approval – Generic Brand Marketing – 180- Day Period (access required)

Administrative – FDA Drug Approval – Generic Brand Marketing – 180- Day Period (access required)

A pharmaceutical company that was the first to qualify to market a generic version of "Macrobid," a drug used to treat urinary tract infections, loses its challenge to the FDA's denial of its petition protesting the marketing of another generic authorized by the company that first developed the drug, during the 180-day "exclusivity" period anticipated ...